Friday, July 10, 2026

pharma · Alopecia areata · Multiple myeloma

First Biotech (Australia)

Pfizer Australia Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Alopecia areata, Multiple myeloma, Heart failure, Acute Migraine (with or without aura), Transthyretin amyloidosi

Norwest House, 710 Collins Street, Melbourne, VIC 3008, AU HQ
2017 Founded
2 Employees
TGA registrant Type
Company details
Status
Public
HQ
Norwest House, 710 Collins Street, Melbourne, VIC 3008, AU
Founded
2017
Employees
2
Programs
126
Drugs
208
Patents
0
Clinical program

A0281007

Phase 1 · other · Primary and secondary hypertension, and heart failure

A0281007 for Primary and secondary hypertension, and heart failure is a Phase 1 program (other) at Pfizer Australia Pty Ltd with 1 ClinicalTrials.gov record(s).

Internal code A0281007

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Pfizer Australia Pty Ltd
Phase
Phase 1
Modality
other
Indication
Primary and secondary hypertension, and heart failure
Status
active
Trials
1